DI SCALA, GERARDO
 Distribuzione geografica
Continente #
NA - Nord America 2.443
EU - Europa 1.432
AS - Asia 927
SA - Sud America 117
AF - Africa 45
OC - Oceania 5
Totale 4.969
Nazione #
US - Stati Uniti d'America 2.408
RU - Federazione Russa 644
SG - Singapore 268
CN - Cina 223
IT - Italia 218
HK - Hong Kong 150
IE - Irlanda 125
SE - Svezia 95
VN - Vietnam 91
BR - Brasile 90
KR - Corea 74
FR - Francia 73
PL - Polonia 72
FI - Finlandia 59
DE - Germania 45
IN - India 38
CH - Svizzera 35
GB - Regno Unito 26
CI - Costa d'Avorio 24
JO - Giordania 24
CA - Canada 16
AR - Argentina 10
ID - Indonesia 10
NL - Olanda 10
MX - Messico 9
BD - Bangladesh 8
MA - Marocco 8
EC - Ecuador 7
ES - Italia 7
IQ - Iraq 7
AT - Austria 6
UA - Ucraina 5
AU - Australia 4
JP - Giappone 4
PE - Perù 4
VE - Venezuela 4
ZA - Sudafrica 4
DO - Repubblica Dominicana 3
PH - Filippine 3
SA - Arabia Saudita 3
TR - Turchia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
EG - Egitto 2
ET - Etiopia 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
MC - Monaco 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MN - Mongolia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
QA - Qatar 1
SO - Somalia 1
TN - Tunisia 1
Totale 4.969
Città #
Santa Clara 563
Ashburn 336
Singapore 179
Fairfield 171
Dublin 125
Hong Kong 121
Chandler 110
San Jose 109
Seattle 84
Houston 78
Woodbridge 76
Seoul 73
Warsaw 72
Beijing 53
Lawrence 53
Altamura 52
Cambridge 52
Wilmington 51
Buffalo 47
Florence 46
Helsinki 43
Moscow 42
Los Angeles 37
New York 34
Bern 33
Princeton 30
Boston 29
Paris 29
Lauterbourg 26
Ho Chi Minh City 25
Abidjan 24
Mumbai 24
Dallas 23
Ann Arbor 22
Hanoi 22
Shanghai 21
The Dalles 20
Munich 19
Hefei 17
Council Bluffs 16
Rome 14
Boardman 13
São Paulo 13
Kent 12
San Diego 11
Turku 11
Jakarta 9
Clifton 8
Guangzhou 8
Medford 8
Milan 8
Orem 8
Bologna 7
Brooklyn 7
Casablanca 7
Chicago 7
Falls Church 7
Redwood City 7
Da Nang 6
Dong Ket 6
Toronto 6
Vienna 6
Bari 5
Belo Horizonte 5
Chennai 5
Frankfurt am Main 5
Jinan 5
Lappeenranta 5
Norwalk 5
Phoenix 5
Stockholm 5
Denver 4
Haiphong 4
Hillsboro 4
London 4
Melbourne 4
Montreal 4
Napoli 4
Washington 4
Amman 3
Baghdad 3
Guayaquil 3
North Bergen 3
Padova 3
Redmond 3
Rieti 3
Taiyuan 3
Tashkent 3
Tokyo 3
Yubileyny 3
Addis Ababa 2
Amsterdam 2
Andover 2
Athens 2
Barnet 2
Basra 2
Benito Juárez 2
Bishkek 2
Biên Hòa 2
Brasília 2
Totale 3.306
Nome #
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 260
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 254
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 210
Practice parameters for sublingual immunotherapy 205
Intravenous immunoglobulin therapy: a snapshot for the internist. 197
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 195
The Presence of Uveitis Is Associated With a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 184
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 183
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: A multicentre study 183
Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus 177
Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis 174
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 174
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 169
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 154
Predictors of Sustained Clinical Response in Patients With Behçet's Disease-Related Uveitis Treated With Infliximab and Adalimumab 154
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study 147
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 144
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 143
ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis 142
Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role 136
Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease 136
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis 135
Vascular Behçet's syndrome: an update 133
Different Drug Survival of First Line Tumour Necrosis Factor Inhibitors in Radiographic and Non-Radiographic Axial Spondyloarthritis: A Multicentre Retrospective Survey 132
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts 128
Clinical profile and evolution of patients with juvenile-onset Behçet’s syndrome over a 25-year period: insights from the AIDA network 126
Prompt Clinical Response to Secukinumab in Patients With Axial Spondyloarthritis: Real Life Observational Data From Three Italian Referral Centers 118
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 109
Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study 108
Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial 104
Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4) 102
Subclinical and Clinical Atherosclerosis in Rheumatoid Arthritis: Results From the 3-year, Multicentre, Prospective, Observational GIRRCS (Gruppo Italiano Di Ricerca in Reumatologia Clinica E Sperimentale) Study 101
Totale 5.017
Categoria #
all - tutte 16.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.024


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 0 0 0 0 0 23 14
2021/2022235 1 8 32 12 2 12 3 30 14 10 47 64
2022/2023595 54 164 20 14 30 88 71 29 62 8 17 38
2023/2024283 12 24 37 19 24 40 16 53 4 18 15 21
2024/20251.650 61 180 76 299 488 175 39 79 82 57 70 44
2025/20261.521 200 206 129 133 184 75 220 75 108 138 53 0
Totale 5.017